RTK class IV; EC 2.7.10.1
| Axon ID | Name | Description | From price | |
|---|---|---|---|---|
| 2849 | Apatinib | Inhibitor of VEGFR2 | €120.00 | |
| 1850 | BMS 540215 | Inhibitor of VEGFR (subtype 2 and 3 selective) | €110.00 | |
| 2837 | BMS 605541 | Potent, selective, orally active, and ATP-competitive VEGFR2 inhibitor | €90.00 | |
| 1864 | Brivanib alaninate | Prodrug of BMS 540215; Inhibitor of VEGF | €90.00 | |
| 1461 | Cediranib | VEGFR tyrosine kinase inhibitor | €70.00 | |
| 1662 | CP 547632 | VEGFR2 tyrosine kinase inhibitor | €70.00 | |
| 3165 | Lenvatinib | Multi-targeted receptor tyrosine kinase inhibitor | €70.00 | |
| 1963 | LY 573636 | Anti-tumor agent; causes growth arrest and apoptosis | €80.00 | |
| 2865 | NVP-ACC789 | Inhibitor of VEGFR2 | €90.00 | |
| 3338 | Taxifolin | Inhibitor of VEGFR2 | €50.00 | |
| 1717 | Tivozanib | VEGFR1, 2, and 3 tyrosine kinase inhibitor | €80.00 | |
| 1637 | Vatalanib | VEGFR tyrosine kinase inhibitor | €75.00 | |
| 3973 | XL-228 | Multitargeted protein kinase inhibitor (IGF1R, Aurora,FGFR, ABL,ALK and SRC) | Inquire | |
| 1978 | ZM 323881 hydrochloride | Inhibitor of VEGFR2 | €105.00 | |